Kala Pharmaceuticals Inc. buy LADENBURG THALM/SH SH
Start price
11.07.25
/
50%
€5.16
Target price
11.07.26
€10.28
Performance (%)
-96.74%
Price
17.04.26
€0.16
Summary
This prediction is currently active. The BUY prediction by LADENBURG_THALM_SH_S for Kala Pharmaceuticals Inc. is performing very badly with a performance of -96.74%. This prediction currently runs until 11.07.26. The prediction end date can be changed by LADENBURG_THALM_SH_S at any time. LADENBURG_THALM_SH_S has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Kala Pharmaceuticals Inc. | -6.471% | -6.471% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by LADENBURG_THALM_SH_S for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for KALA provided by MarketBeat